Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal J Meropol

Showing results (131-140 of 226) with videos related to

Pageof 23
Sort By:
Journal of Oncology Practice|August 15, 2013
Cost concerns of patients with cancerTammy K Stump, Naa Eghan, Brian L Egleston, et al.
Medical Care|July 23, 2013
Cancer patients' trade-offs among efficacy, toxicity, and out-of-pocket cost in the curative and noncurative settingYu-Ning Wong, Brian L Egleston, Kush Sachdeva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancerAhmad L Subhi, Baiqing Tang, Binaifer R Balsara, et al.
Patient Education and Counseling|April 1, 2017
A stakeholder-driven approach to improve the informed consent process for palliative chemotherapyAndrea C Enzinger, Jennifer K Wind, Elizabeth Frank, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|May 7, 2009
A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblingsSharon L Manne, Elliot J Coups, Arnold Markowitz, et al.
International Journal of Cancer|December 23, 2009
Nucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patientRolf K Swoboda, Rajasekharan Somasundaram, Laura Caputo, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 2, 2008
Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consentKevin P Weinfurt, Damon M Seils, Janice P Tzeng, et al.
Seminars in Oncology|January 10, 2006
Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experienceAndre Konski, John Hoffman, Elin Sigurdson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2007
Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancerGary M Freedman, Neal J Meropol, Elin R Sigurdson, et al.
Clinical Colorectal Cancer|August 24, 2011
Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiativeMargaret A O'Grady, Elyse Slater, Elin R Sigurdson, et al.
Pageof 23

Showing results (131-140 of 226) with videos related to

Sort By:
Pageof 23
Journal of Oncology Practice|August 15, 2013
Cost concerns of patients with cancerTammy K Stump, Naa Eghan, Brian L Egleston, et al.
Medical Care|July 23, 2013
Cancer patients' trade-offs among efficacy, toxicity, and out-of-pocket cost in the curative and noncurative settingYu-Ning Wong, Brian L Egleston, Kush Sachdeva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancerAhmad L Subhi, Baiqing Tang, Binaifer R Balsara, et al.
Patient Education and Counseling|April 1, 2017
A stakeholder-driven approach to improve the informed consent process for palliative chemotherapyAndrea C Enzinger, Jennifer K Wind, Elizabeth Frank, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|May 7, 2009
A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblingsSharon L Manne, Elliot J Coups, Arnold Markowitz, et al.
International Journal of Cancer|December 23, 2009
Nucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patientRolf K Swoboda, Rajasekharan Somasundaram, Laura Caputo, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 2, 2008
Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consentKevin P Weinfurt, Damon M Seils, Janice P Tzeng, et al.
Seminars in Oncology|January 10, 2006
Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experienceAndre Konski, John Hoffman, Elin Sigurdson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2007
Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancerGary M Freedman, Neal J Meropol, Elin R Sigurdson, et al.
Clinical Colorectal Cancer|August 24, 2011
Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiativeMargaret A O'Grady, Elyse Slater, Elin R Sigurdson, et al.
Pageof 23